Close Menu

NEW YORK — Trinity Biotech on Wednesday posted a nearly 4 percent drop year over year in first quarter revenues as lower clinical laboratory revenues more than offset an increase in sales of its point-of-care products.

For the three-month period ended March 31, Trinity posted revenues of $21.2 million versus $22.0 million in the year-ago quarter.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.